Andrea van Elsas
InvestorPartner at Third Rock Ventures
Oakland, California
Writes $100K – $5M checks · typically $100K
Find your path to Andrea
229 people in our graph share verified history with Andrea — schools, employers, funds. One of them is your warm intro.
René KuijtenunlockedAndrea: together at University of Amsterdam (1988–1990)
×11Andrea: together at Third Rock Ventures
About
Andrea van Elsas joined Third Rock Ventures as a venture partner in 2020 and became partner in 2022. He was previously CSO at Aduro Biotech, co-founded BioNovion, held immuno-oncology roles at Organon, and is a co-inventor on the original anti-CTLA-4 patents behind ipilimumab.
Contact· published on Andrea's own website
Invests in
BiotechHealthtechMedical Devices
Experience
- Third Rock VenturesPartnercurrent2022 — presentSan Francisco Bay Area
- Third Rock VenturesVenture Partner2020 — 2022San Francisco Bay Area
- Azalea TherapeuticsBoard Membercurrent2025 — presentBerkeley, California, United States
- Clasp TherapeuticsBoard Membercurrent2023 — presentBoston, Massachusetts, United States
- Clasp TherapeuticsChief Scientific Officer2021 — 2024Cambridge, Massachusetts, United States
- IREYA Consulting BVOwnercurrent2011 — presentOss, Netherlands
- Lava Therapeutics B.V.Scientific Advisory Board Chair2018 — 2025Netherlands
- Lava Therapeutics B.V.Board Member2018 — 2020Netherlands
Skills & more
Immunology50Oncology22
Languages Dutch · English
From Andrea's professional profile.
Investments
Board seats
Azalea TherapeuticsClasp TherapeuticsLava Therapeutics
Per the firm's website.
Colleagues at Third Rock Ventures
Abbie Celniker
Investor at Third Rock Ventures
Adam Tebbe
Investor at Third Rock Ventures
Alan Ezekowitz
Investor at Third Rock Ventures
Alexis Borisy
General Partner at Third Rock Ventures
Alison Connors
Investor at Third Rock Ventures
Amanda Chan
Investor at Third Rock Ventures
Angelo Severino
Investor at Third Rock Ventures
Ava Brunelle
Investor at Third Rock Ventures
Network11
Abbie Celniker
Investor at Third Rock Ventures
Alan Ezekowitz
Investor at Third Rock Ventures
Andrew Warren
Senior Associate at Third Rock Ventures
Barbara Weber
Venture Partner at Third Rock Ventures
Beryl Cummings
Senior Associate at Third Rock Ventures
Cary Pfeffer
Investor at Third Rock Ventures
Charles Homcy
Investor at Third Rock Ventures
Christoph Lengauer
CSO at Curie.Bio
Craig Muir
Investor at Third Rock Ventures
David Kaufman
Investor at Third Rock Ventures
George C. Petrocheilos
Co-Founder and Managing Partner at Catalio Capital Management, LP
Investors connected to Andrea in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Andrea van Elsas?
- Andrea van Elsas joined Third Rock Ventures as a venture partner in 2020 and became partner in 2022. He was previously CSO at Aduro Biotech, co-founded BioNovion, held immuno-oncology roles at Organon, and is a co-inventor on the original anti-CTLA-4 patents behind ipilimumab.
- Where does Andrea van Elsas work?
- Andrea van Elsas is Partner at Third Rock Ventures.
- What does Andrea van Elsas invest in?
- Andrea van Elsas invests in Biotech, Healthtech, Medical Devices.
- What check size does Andrea van Elsas write?
- Andrea van Elsas typically writes checks of $100K – $5M.
- What boards does Andrea van Elsas sit on?
- Andrea van Elsas holds tracked board seats at Azalea Therapeutics, Clasp Therapeutics, Lava Therapeutics.
- Where did Andrea van Elsas go to school?
- Andrea van Elsas studied at Leiden University (PhD, Immunology, Oncology); University of Amsterdam (MS, Molecular and Cell Biology).
Same school
Also attended Leiden University121
Joost HollemanInvestor at Prime VenturesFredric PetitPartner, Head of Materials & Packaging at Emerald Technology Ventures AgJeroen PlinkVenture Partner at LegalTechThijs SchaapInvestment manager at NoaberRoel BulthuisInvestor at SynconaAina CabreroInvestor & Scientist at Planet A Ventures
+ 115 more
Also attended University of Amsterdam291
Job van der VoortCo-founder & CEO of RemoteMartijn KleijwegtInvestor at LSP (Life Sciences Partners)René KuijtenInvestor at LSP (Life Sciences Partners)TorjusInvestor at InvestinorDamien van der BijlInvestment Director at Capricorn Venture PartnersFreya WordsworthAssociate at Nauta Capital
+ 285 more
Shared employers
Also worked at Third Rock Ventures88
Lisa PurcellInvestor at Third Rock VenturesPaul MeloneInvestor at Third Rock VenturesLee VeneziaInvestor at Third Rock VenturesKevin MunnellyInvestor at Third Rock VenturesAmanda ChanInvestor at Third Rock VenturesJigar RaythathaInvestor at Third Rock Ventures
+ 82 more
